South & Central America Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis

Description

List of Tables

The South & Central America non-invasive ventilation masks market was valued at US$ 80.24 million in 2023 and is expected to reach US$ 115.12 million by 2031; it is estimated to register a CAGR of 4.6% from 2023 to 2031.

Increasing Adoption of NIV Masks Fuels South & Central America Non-Invasive Ventilation Masks Market

Noninvasive ventilation masks are becoming increasingly popular and expanding market opportunities by spurring innovation. Earlier diagnosis and treatment are being made possible by growing awareness campaigns about respiratory disorders such as COPD, sleep apnea, and others. The increased prescription and usage of NIV masks for disease management results from greater awareness among patients and healthcare professionals. Thus, emerging awareness of early diagnosis is likely to drive the adoption of NIV masks and create significant opportunities in the market. Moreover, respiratory illnesses are becoming more common in emerging economies, particularly in Asia Pacific, Latin America, and the Middle East, due to pollution, urbanization, and lifestyle changes. The Noninvasive therapies are becoming widely known in these areas, owing to which the use of NIV masks is likely to continue to propel during the forecast period.

South & Central America Non-Invasive Ventilation Masks Market Overview

The South & Central America noninvasive ventilation masks market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in this region is expected to grow due to the increasing prevalence of COPD, OSA, and ARF; the rising number of research and developmental activities; and investment in healthcare systems. Additionally, supportive government guidelines and the rising adoption of NIV in private and public hospitals in the region are expected to bring opportunities for the market players to expand their operations in emerging economies such as Brazil and Argentina.

South & Central America Non-Invasive Ventilation Masks Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Non-Invasive Ventilation Masks Market Segmentation

The South & Central America non-invasive ventilation masks market is categorized into product, application, end user, and country.

By product, the South & Central America non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the South & Central America non-invasive ventilation masks market share in 2023.

In terms of application, the South & Central America non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share of the South & Central America non-invasive ventilation masks market share in 2023.

Based on end user, the South & Central America non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held the largest share of the South & Central America non-invasive ventilation masks market share in 2023.

Based on country, the South & Central America non-invasive ventilation masks market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil segment held the largest share of South & Central America non-invasive ventilation masks market in 2023.

Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD. are some of the leading companies operating in the South & Central America non-invasive ventilation masks market.

Product Code: TIPRE00028748

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Non-Invasive Ventilation Masks Market Landscape

4.1 PEST Analysis

5. South & Central America Non-Invasive Ventilation Masks Market - Key Market Dynamics

5.1 South & Central America Non-Invasive Ventilation Masks Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Respiratory Diseases
- 5.2.2 Growing Inclination Towards Home Healthcare
5.3 Market Restraints
- 5.3.1 Side Effects Associated with NIV Masks
5.4 Market Opportunities
- 5.4.1 Increasing Adoption of NIV Masks
5.5 Future Trends
- 5.5.1 Rising Technological Advancements
5.6 Impact of Drivers and Restraints:

6. South & Central America Non-Invasive Ventilation Masks Market - Analysis

6.1 South & Central America Non-Invasive Ventilation Masks Market Revenue (US$ Million), 2021-2031
6.2 South & Central America Non-Invasive Ventilation Masks Market Forecast Analysis

7. South & Central America Non-Invasive Ventilation Masks Market Analysis - by Product

7.1 Non-Invasive Ventilation Disposable Mask
- 7.1.1 Overview
- 7.1.2 Non-Invasive Ventilation Disposable Mask: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Non-Invasive Ventilation Reusable Mask
- 7.2.1 Overview
- 7.2.2 Non-Invasive Ventilation Reusable Mask: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Non-Invasive Ventilation Masks Market Analysis - by Application

8.1 Sleep Apnea
- 8.1.1 Overview
- 8.1.2 Sleep Apnea: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Chronic Obstructive Pulmonary Disease
- 8.2.1 Overview
- 8.2.2 Chronic Obstructive Pulmonary Disease: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Pneumonia
- 8.3.1 Overview
- 8.3.2 Pneumonia: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Non-Invasive Ventilation Masks Market Analysis - by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Home Care
- 9.2.1 Overview
- 9.2.2 Home Care: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Non-Invasive Ventilation Masks Market - Country Analysis

10.1 South & Central America
- 10.1.1 South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Brazil: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Brazil: South & Central America Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.2.2 Brazil: South & Central America Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.2.3 Brazil: South & Central America Non-Invasive Ventilation Masks Market Share - by End User
  - 10.1.1.3 Argentina: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Argentina: South & Central America Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.3.2 Argentina: South & Central America Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.3.3 Argentina: South & Central America Non-Invasive Ventilation Masks Market Share - by End User
  - 10.1.1.4 Rest of South & Central America: South & Central America Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Rest of South & Central America: South & Central America Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.4.2 Rest of South & Central America: South & Central America Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.4.3 Rest of South & Central America: South & Central America Non-Invasive Ventilation Masks Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Noninvasive Ventilation Mask Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Hamilton Medical AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 ResMed Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Fisher & Paykel Healthcare Corp Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Air Liquide Medical Systems
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Dragerwerk AG & Co KGaA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Intersurgical Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 BMC Medical Co Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 DeVilbiss Healthcare LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Armstrong Medical Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Koninklijke Philips NV
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Besmed Health Business Corp
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Sleepnet Corporation.
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 SunMed Group Holdings LLC ( AirLife)
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Dimar S.P.A.
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Hangzhou Formed Medical Devices Co., Ltd
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 SURU INTERNATIONAL PVT. LTD.
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Medline Industries LP
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments

13. Appendix

13.1 About Us
13.2 List of Abbreviations